These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32883292)

  • 1. Impact of multidisciplinary tumour boards (MTB) on the clinicopathological characteristics and outcomes of resected colorectal liver metastases across time.
    Chen L; Syn NL; Goh BKP; Cheow PC; Raj P; Koh Y; Chung A; Lee SY; Ooi LL; Chan CY; Teo JY
    World J Surg Oncol; 2020 Sep; 18(1):237. PubMed ID: 32883292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the surgical management for non-colorectal liver metastases.
    Luk Y; She WH; Tsang SHY; Dai WC; Chan ACY; Cheung TT; Lo CM
    Langenbecks Arch Surg; 2023 Jan; 408(1):35. PubMed ID: 36648566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 8. Time-varying prognostic effects of primary tumor sidedness and grade after curative liver resection for colorectal liver metastases.
    Syn NL; Chua DW; Raphael Chen L; Tan YC; Goh BKP; Chung Cheow P; Jeyaraj PR; Koh Y; Chung A; Yee Lee S; Lucien Ooi L; Tai BC; Yip Chan C; Teo JY
    Surg Oncol; 2021 Sep; 38():101586. PubMed ID: 33933898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
    Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
    Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
    Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
    World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type of response to conversion chemotherapy strongly impacts survival after hepatectomy for initially unresectable colorectal liver metastases.
    Zimmitti G; Panettieri E; Ardito F; Rosso E; Mele C; Nuzzo G; Giuliante F
    ANZ J Surg; 2020 Apr; 90(4):558-563. PubMed ID: 31927783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse oncological outcome of surgical site infection after liver resection for colorectal liver metastases.
    Fukami Y; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y
    Surg Today; 2019 Feb; 49(2):170-175. PubMed ID: 30225661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Omichi K; Shindoh J; Cloyd JM; Mizuno T; Chun YS; Conrad C; Aloia TA; Tzeng CD; Vauthey JN
    Eur J Surg Oncol; 2018 Jan; 44(1):122-129. PubMed ID: 29208318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term survival outcome after curative hepatectomy between selected patients with non-colorectal and colorectal liver metastasis: A propensity score matching analysis.
    Lok HT; Fung AKY; Chong CCN; Lee KF; Wong J; Cheung SYS; Lai PBS; Ng KKC
    Asian J Surg; 2021 Feb; 44(2):459-464. PubMed ID: 33229125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
    Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
    Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.